1Vote!
Radon Mitigation Pittsburgh (Free subscription) | 07/10/2009
(EMAILWIRE.COM, July 10, 2009 ) DALLAS, Texas InvestorSoup.com announces the release of Stock Alerts covering market movers: Alcoa Inc. (NYSE: AA), Google Inc. (Nasdaq: GOOG), NRG Energy Inc. (NYSE: NRG), Cisco Systems Inc. (Nasdaq: CSCO) and Amylin Pharmaceuticals Inc. (Nasdaq: AMLN). The stock alert features the most recent headlines, share price and technical analysis for each covered company. The...
Explore : Alcoa Inc.,
Aluminium,
Biotechnologies,
Business,
Cisco Systems,
Google Inc.,
Internet,
Mining,
NRG Energy Inc.,
Raw,
Technology,
Wrestling
1Vote!
Market Wire (Free subscription) | 06/19/2009
NEW DELHI, INDIA (MARKET WIRE) W.S.S. is an online community with a dedicated team of analysts who are providing free in-depth research on North American equities. Our analysts have issued free ratings reports on the following four companies: Atmel Corp. (NASDAQ: ATML), UTI Worldwide Inc. (NASDAQ: UTIW), Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) and RF Micro Devices Inc. (NASDAQ: RFMD).
5Vote!
The Business Courier of Cincinnati (Free subscription) | 05/05/2009
Amylin Pharmaceuticals Inc., Eli Lilly and Co. and Alkermes Inc. have submitted to the Food and Drug Administration a new drug application for a once-weekly formulation of exenatide, the companies said Tuesday. (AMLN) (LLY) (ALKS)
5Vote!
The Business Courier of Cincinnati (Free subscription) | 04/30/2009
Amylin Pharmaceuticals Inc. and Eli Lilly and Co. will work together to develop and market a new delivery device for exenatide, a treatment for type 2 diabetes. (AMLN) (LLY)
1Vote!
Miami Herald (Free subscription) | 04/20/2009
Amylin Pharmaceuticals Inc. said Monday activist investor Carl Icahn plans to push for a sale of the company to drugmaker Eli Lilly if he can take control of Amylin's board of directors.
5Vote!
Seattle Times (Free subscription) | 04/20/2009
Amylin Pharmaceuticals Inc. said Monday activist investor Carl Icahn plans to push for a sale of the company to drugmaker Eli Lilly if he can take control of Amylin's board of directors.
5Vote!
The Atlanta Business Chronicle (Free subscription) | 04/01/2009
Altea Therapeutics inked a deal worth up to $46 million with Eli Lilly and Co. and Amylin Pharmaceuticals Inc. to develop and commercialize a daily transdermal patch that delivers exenatide using Altea’s PassPort Transdermal Delivery System. (LLY) (AMLN)
1Vote!
Drug Injury Watch (Free subscription) | 03/16/2009
Nonetheless, Pending Byetta Label Change Will Probably Add Stronger Warnings About Severe Pancreatitis Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) As some may recall, in August 2008 the FDA issued a MedWatch alert about six cases of hemorrhagic pancreatitis...
4Vote!
Business Wire (Free subscription) | 03/09/2009
SAN RAFAEL, Calif.--(BUSINESS WIRE)--Eastbourne Capital Management, L.L.C. (“Eastbourne”) today delivered a letter to the Amylin Pharmaceuticals, Inc. (“Amylin”) (NASDAQ: AMLN) Board of
5Vote!
The Street (Free subscription) | 02/05/2009
Amylin shares are rising on news that billionaire investor Carl Icahn is building his position in the company.
4Vote!
Forbes (Free subscription) | 02/05/2009
Carl Icahn boosts his stake in the diabetes player, and some kind of a sale appears to be a foregone conclusion.
3Vote!
RentBusinessAudiobooks.com Blog (Free subscription) | 02/05/2009
Carl Icahn boosts his stake in the diabetes player, and some kind of a sale appears to be a foregone conclusion.
Videos